tirzepatide and thyroid medication Tirzepatide and Thyroid Nodules: Safety

Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating

The REWIND trial with dulaglutide and SUSTAIN-6 with semaglutide also demonstrated cardiovascular benefits

A 2025 FAERS (FDA adverse event reporting system) analysis found a reporting odds ratio of about 1.9 for depression with semaglutide

10.1016/0014-5793(95)01185-H [DOI] [PubMed] [Google Scholar] Meunier J

Unproven peptides will be easier to get after a federal advisory committee including some peptide promoters voted on July 23 and 24 to allow compounding pharmacies to distribute several of these injectable substances